Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins

A fully effective antimalarial vaccine must contain multiple proteins from the different development stages of Plasmodium falciparum parasites involved in host-cell invasion or their biologically active fragments. It must therefore include sporozoite molecules able to induce protective immunity by b...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2009
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23506
Acceso en línea:
https://doi.org/10.1016/j.bbrc.2009.04.138
https://repository.urosario.edu.co/handle/10336/23506
Palabra clave:
HLA DR antigen
Liver stage antigen 1
Major histocompatibility antigen class 2
Malaria vaccine
Parasite antigen
Plasmodium falciparum malarial protein
Protozoal protein
Sporozoite and liver stage antigen
T lymphocyte receptor
Unclassified drug
Animal cell
Animal experiment
Animal model
Animal tissue
Antigen structure
Article
Cell invasion
Controlled study
Host parasite interaction
Immune response
Immunogenicity
Liver cell
Malaria
Monkey
Nonhuman
Nucleotide sequence
Plasmodium falciparum
Priority journal
Sporozoite
Amino Acid Sequence
Animals
HLA-DR Antigens
Immunization
Liver
Malaria Vaccines
Molecular Sequence Data
Plasmodium falciparum
Protozoan Proteins
Plasmodium falciparum
HLA-dr?1* molecules
LSA-1
Malaria
MHCII-peptide-TCR complex
SALSA
Subunit
Protozoan
Secondary
Antigens
Protein Structure
Vaccines
Rights
License
Abierto (Texto Completo)
Description
Summary:A fully effective antimalarial vaccine must contain multiple proteins from the different development stages of Plasmodium falciparum parasites involved in host-cell invasion or their biologically active fragments. It must therefore include sporozoite molecules able to induce protective immunity by blocking the parasite's access to hepatic cells, and/or proteins involved in the development of this stage, amongst which are included the Liver Stage Antigen-1 (LSA-1) and the Sporozoite and Liver Stage Antigen (SALSA). Our studies have focused on the search for an association between the structure of high activity binding peptides (HABPs), including both conserved native and their modified analogues, and their ability to bind to the MHC Class II HLA-DR molecules during formation of the MHCII-peptide-TCR complex leading to inducing the appropriate immune response. These studies are part of a logical and rational strategy for developing multi-stage, multi-component, minimal subunit-based vaccines, mainly against the P. falciparum malaria. © 2009 Elsevier Inc. All rights reserved.